Uncategorized

2206-54328

Increasing Access to Safe Abortion for Underserved Women through Innovative Financing Model and Next Generation Mobilization

  DKT INTERNATIONAL, INC           Ethiopia

DKT International (DKT)’s funded innovation is a partnership initiative between DKT’s Ethiopian branch and private health clinics, and a grassroots demand generation model, to help underprivileged women access safe abortion services and improve private clinic services. DKT will select at least 30 private-sector partner clinics to participate in the initiative, prioritizing localities in Addis Abba and a minimum of 1-2 major towns with the highest rates of unsafe abortion among underserved women. Clinic staff will be trained on MA and MVA. DKT will sell MA, MVA and contraception products to the clinics at cost and for every 10 clients seeking safe abortion; clinics commit to providing one free service and a month contraceptive product of choice for an underserved client, with the service and product cost for the underserved client reimbursed by DKT. DKT will establish a new easily remembered national toll-free helpline number to operationalize this innovation.They will partner with Triggerise Ethiopia, as 25 Triggerise “Tiko Pros” community mobilizers will direct underprivileged women to the hotline.

 

 

Uncategorized

2202-60190

Quality-assured mifepristone as emergency contraception: A next generation option for an existing abortion pill

  Concept Foundation    Argentina, Ethiopia, Ghana, Netherlands, Sweden, Tanzania, Thailand, and Switzerland

Concept Foundation seeks to expand the regulatory pathway of mifepristone an as emergency contraceptive in low- and middle-income countries, exploring pathways to bring mifepristone as a quality-assured, low-cost, over the counter emergency contraceptive to market. Concept Foundation will prepare a data package to demonstrate mifepristone can be registered using existing evidence, supported by an advisory committee. Once the data package is finalized, Concept Foundation will meet with regulatory authorities and agencies to establish pathways to register mifepristone as a quality-assured emergency contraceptive product.

Uncategorized

2104-38233

Developing new methods and devices for later abortion

  Consultants in Obstetric and Gynecologic Ultrasonography and Surgery, PLLC
Ethiopia, United States, and Mexico

The Dupont Clinic innovation evaluates three devices in different countries to improve the provision of later safe abortion. Three provider sites in Mexico, Ethiopia, and the United States will develop and implement these new methods: Lidocaine for fetal demise, DuPont Cannula, and a novel cervical dilation device. Patient and provider feedback will be provided by the sites, and will cover a range of facility sizes and patient populations. The combination of these technologies will make later abortion safer, simpler, and more feasible in most settings.